Morino Kazuya, Miyake Masahiro, Nagasaki Masao, Kawaguchi Takahisa, Numa Shogo, Mori Yuki, Yasukura Shota, Akada Masahiro, Nakao Shin-Ya, Nakata Ai, Hashimoto Hiroki, Otokozawa Ryoko, Kamoi Koju, Takahashi Hiroyuki, Tabara Yasuharu, Matsuda Fumihiko, Ohno-Matsui Kyoko, Tsujikawa Akitaka
Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Department of Ophthalmology, Kyoto University Graduate School of Medicine, Kyoto, Japan; Center for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ophthalmol Retina. 2025 Apr;9(4):367-377. doi: 10.1016/j.oret.2024.09.016. Epub 2024 Nov 1.
To identify the susceptibility loci for myopic macular neovascularization (mMNV) in patients with high myopia.
A genome-wide association study (GWAS) meta-analysis (meta-GWAS).
We included 2783 highly myopic individuals, including 608 patients with mMNV and 2175 control participants without mMNV.
We performed a meta-analysis of 3 independent GWASs conducted according to the genotyping platform (Illumina Asian Screening Array [ASA] data set, Illumina Human610 BeadChip [610K] data set, and whole genome sequencing [WGS] data set), adjusted for age, sex, axial length, and the first to third principal components. We used DeltaSVM to evaluate the binding affinity of transcription factors (TFs) to DNA sequences around the susceptibility of single nucleotide polymorphisms (SNPs). In addition, we evaluated the contribution of previously reported age-related macular degeneration (AMD) susceptibility loci.
The association between SNPs and mMNV in patients with high myopia.
The meta-GWAS identified rs56257842 at TEX29- LINC02337 as a novel susceptibility SNP for mMNV (odds ratio [OR] = 0.62, P = 4.63 × 10, I = 0.00), which was consistently associated with mMNV in all data sets (OR = 0.59, P = 1.71 × 10; OR = 0.63, P = 5.53 × 10; OR = 0.66, P = 4.38 × 10). Transcription factor-wide analysis showed that the TFs ZNF740 and EGR1 lost their binding affinity to this locus when rs56257842 had the C allele (alternative allele), and the WNT signaling-related TF ZBTB33 gained binding affinity when rs56257842 had the C allele. When we examined the associations of AMD susceptibility loci, rs12720922 at CETP showed a statistically significant association with mMNV (OR = 0.52, P = 1.55 × 10), whereas rs61871745 near ARMS2 showed a marginal association (OR = 1.25, P = 7.79 × 10).
Our study identified a novel locus associated with mMNV in high myopia. Subsequent analyses offered important insights into the molecular biology of mMNV, providing the potential therapeutic targets for mMNV. Furthermore, our findings imply shared genetic susceptibility between mMNV and AMD.
FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
确定高度近视患者中近视性黄斑新生血管形成(mMNV)的易感基因座。
全基因组关联研究(GWAS)荟萃分析(meta-GWAS)。
我们纳入了2783名高度近视个体,其中包括608例mMNV患者和2175名无mMNV的对照参与者。
我们根据基因分型平台(Illumina亚洲筛查芯片[ASA]数据集、Illumina Human610 BeadChip[610K]数据集和全基因组测序[WGS]数据集)对3项独立的GWAS进行荟萃分析,并对年龄、性别、眼轴长度和第一至第三主成分进行了校正。我们使用DeltaSVM评估转录因子(TFs)与单核苷酸多态性(SNPs)易感性周围DNA序列的结合亲和力。此外,我们评估了先前报道的年龄相关性黄斑变性(AMD)易感基因座的贡献。
高度近视患者中SNP与mMNV之间的关联。
meta-GWAS确定TEX29-LINC02337处的rs56257842为mMNV的一个新的易感SNP(优势比[OR]=0.62,P=4.63×10,I=0.00),在所有数据集中该SNP均与mMNV一致相关(OR=0.59,P=1.71×10;OR=0.63,P=5.53×10;OR=0.66,P=4.38×10)。全转录因子分析表明,当rs56257842具有C等位基因(替代等位基因)时,TFs ZNF740和EGR1失去了与该基因座的结合亲和力,而当rs56257842具有C等位基因时,WNT信号相关TF ZBTB33获得了结合亲和力。当我们检查AMD易感基因座的关联时,CETP处的rs12720922与mMNV显示出统计学上的显著关联(OR=0.52,P=1.55×10),而ARMS2附近的rs61871745显示出边缘关联(OR=1.25,P=7.79×10)。
我们的研究确定了一个与高度近视患者的mMNV相关的新基因座。后续分析为mMNV的分子生物学提供了重要见解,为mMNV提供了潜在的治疗靶点。此外,我们的研究结果暗示了mMNV与AMD之间存在共同的遗传易感性。
在本文末尾的脚注和披露中可能会发现专有或商业披露信息。